Literature DB >> 1646904

Hormonal regulation of plasminogen activator and peroxidase activities in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors and the rat uterus.

K Inada1, J Yamashita, T Yoshimura, S Matsuo, Y Nakashima, S Yamashita, A Misumi, M Ogawa.   

Abstract

Oophorectomy was found to decrease the plasminogen activator activity of rat mammary tumors induced by 7,12-dimethylbenz(a)anthracene (DMBA) to less than 7 per cent, while in vivo estradiol treatment restored its activity in a dose dependent fashion. The peroxidase activity was not changed either by oophorectomy or by the administration of estrogen. In the rat uterus, plasminogen activator activity was not changed by oophorectomy or by the administration of estrogen, however, its peroxidase activity decreased to less than 2 per cent following oophorectomy, while estrogen administration restored its activity. Estrogen regulated plasminogen activator activity in the DMBA-induced rat mammary tumors but not in the uterus and thus, the specific hormonal regulation of this enzyme may be an important factor for the hormonal dependent growth of such tumors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1646904     DOI: 10.1007/bf02470918

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  21 in total

1.  EFFECT OF INHIBITORS OF FIBRINOLYTIC ENZYMES ON DEVELOPMENT OF PULMONARY METASTASES.

Authors:  E E CLIFFTON; D AGOSTINO
Journal:  J Natl Cancer Inst       Date:  1964-11       Impact factor: 13.506

2.  THE UPTAKE OF (6,7-3-H)OESTRADIOL BY DIMETHYLBENZANTHRACENE-INDUCED RAT MAMMARY TUMOURS.

Authors:  R J KING; D M COWAN; D R INMAN
Journal:  J Endocrinol       Date:  1965-04       Impact factor: 4.286

3.  Plasminogen activator as a functional marker for estrogen dependence in human breast cancer cells.

Authors:  J Yamashita; S Horiuchi; M Kimura; R Nishimura; M Akagi
Journal:  Jpn J Cancer Res       Date:  1986-02

4.  Fibrinolysis associated with human neoplasia: production of plasminogen activator by human tumours.

Authors:  B Nagy; J Ban; B Brdar
Journal:  Int J Cancer       Date:  1977-05-15       Impact factor: 7.396

5.  The uptake of tritiated oestradiol by dimethylbenzanthracene-induced mammary tumours of the rat.

Authors:  B G Mobbs
Journal:  J Endocrinol       Date:  1966-12       Impact factor: 4.286

6.  Relationship between fibrinolysis of cultured cells and malignancy.

Authors:  W E Laug; P A Jones; W F Benedict
Journal:  J Natl Cancer Inst       Date:  1975-01       Impact factor: 13.506

7.  Estrogen-dependent plasminogen activator in 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors in vivo and in vitro.

Authors:  J Yamashita; S Horiuchi; N Shigaki; N Fujino; M Akagi
Journal:  Gan       Date:  1984-08

8.  Effects of sex steroids on the development of 7,12-dimethylbenz[a]anthracene-induced mammary dysplasia in neonatally androgenized female rats.

Authors:  H Yoshida; R Fukunishi
Journal:  Gan       Date:  1981-04

9.  Measurement of nuclear estrogen receptors by charcoal adsorption: relationships of cytoplasmic and nuclear estrogen receptors and progesterone receptors in human breast cancer.

Authors:  R Nishimura; M Kimura; T Tokunaga; M Akagi
Journal:  Gan       Date:  1982-10

10.  Biological characteristics and estrogen and progesterone receptors in mammary carcinoma induced in male Sprague-Dawley rats by a series of intragastric intubations of 7,12-dimethylbenz(a)anthracene.

Authors:  H Yoshida; A Yoshida; R Fukunishi; B Sato; S Okamoto; K Matsumoto
Journal:  Cancer Res       Date:  1982-06       Impact factor: 12.701

View more
  3 in total

1.  Hormone control of total plasminogen activator activity is specific to malignant DMBA-induced rat mammary tumours.

Authors:  K Inada; J Yamashita; S Matsuo; Y Nakashima; S Yamashita; M Ogawa
Journal:  Br J Cancer       Date:  1992-04       Impact factor: 7.640

2.  Differential biological significance of tissue-type and urokinase-type plasminogen activator in human breast cancer.

Authors:  J Yamashita; M Ogawa; S Yamashita; Y Nakashima; T Saishoji; K Nomura; K Inada; I Kawano
Journal:  Br J Cancer       Date:  1993-09       Impact factor: 7.640

3.  Breast cancer prognosis is poor when total plasminogen activator activity is low.

Authors:  J Yamashita; M Ogawa; K Inada; S Yamashita; Y Nakashima; T Saishoji; K Nomura
Journal:  Br J Cancer       Date:  1993-02       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.